Breast implant surgery should not be performed in women due to the following conditions:
Breast implant surgery, which is often performed using general anesthesia, is associated with the same risks as other invasive surgical procedures. Complications vary in accordance to the patient. After breast implant surgery, patients may experience the following symptoms over the first few weeks:
Additional potential adverse events that may occur with silicone gel-filled breast implant surgery also include:
If you are unfamiliar with the previously mentioned terminology and would like to learn more please contact your doctor and / or surgeon. For any additional information please refer to: https://motivaimplants.com
Yes, the microtransponder (Qid™) is MRI safe. The device is MRI conditional meaning that it has demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use.
This microtransponder may create an imaging void during a breast implant MRI (known as an artifact effect) that can block visualization of a small area of minor breast tissue near the Qid™. In selected cases, alternative imaging techniques such as ultrasounds, tomosynthesis, digital compression mammogrammy, subtraction contrast mammography and scintimammography can be used to better visualize the region affected by the implant Qid™.
The Motiva Implants that give a round aesthetic appearance are the Motiva Implants® Round with ProgressiveGel PLUS, which provides the highest projection and a complete filling of the upper pole.
It is however important to mention that the desired results for each patient should be evaluated individually by the surgeon.
Round implants provide a higher top and a more full-bodied appearance. They are the most common implants and are used in almost 80 percent of all breast augmentation surgeries.
Anatomical implants are often called tear-drop-shaped because they are designed to simulate the shape of a natural breast. While the result with an anatomical implant is natural looking, the predefined shape means the implant lacks natural movement and doesn’t shift with the body’s movements. For example, when a patient with anatomical implants moves from lying down to a standing position there is a noticeable lack of breast movement. This is because the implant retains the same shape wether the patient is prone, supine or upright.
Motiva’s Ergonomix® implants avoids this drawback by using a unique gel, which is very soft, allowing the implant to follow a women’s natural movement, holding a round shape when lying down and assuming a teardrop shape when standing. This gives a very natural appearance, both in look and feel.
The Q Inside Safety Technology is the world’s first FDA approved transponder for use in humans cleared in 2004 and the only one with CE-Mark when used in a breast implant. The microtransponder is a device which is placed in the breast implant filler material. Motiva Implants® with Qid™ contains a transponder that provides electronic serial number data through an external reader for traceability and quality assurance purposes.
This microtransponder has been separately reviewed and cleared for marketing by the U.S. Food and Drug Administration for use as an implantable microchip that is inserted into the subcutaneous tissue of a patient to provide the patient an electronic serial number that may be used to access a database containing the patient’s identity and health information.
a.
b.
To extend the coverage of your Motiva Implants® silicome breast implants; Motiva offers an Extended Warranty Program that applies to qualifying Motiva Implants® silicone breast implants, through an additional fee to be covered by or on behalf of the patient during de first 90 days after the initial breast surgery as specified below:
a.
b.
c.
d.
Qualified Motiva breast implant for the 2Y Extended Warranty are as follows:
Qualified Motiva breast implant for Free First Year and 5Y Extended Warranty are as follows
Establishment Labs may exclude from the applicable warranty program patients with previous history of capsular contracture Baker grades III and IV.